caratherapeutics.com (TVRD) - מזומנים למניה

סמל תאגידי ולוגו של Cara Corp (TVRD)

The development of drugs for renal pruritus is independent of macroeconomics and seasonality, demonstrating high resilience. The estimated cash per share clearly illustrates the current situation, where the 1.68 mark characterizes this parameter. Cara Therapeutics Inc (TVRD) focuses on therapy for dialysis patients, however, management is currently urgently reducing headcount following failed trials in an attempt to restore investor confidence.

caratherapeutics.com (TVRD) - מזומנים למניה אחת מ-04.07.2022 עד 21.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Cara Corp (TVRD)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:Cara Pharma - TVRD
סחורת הדגל של Cara Pharma

By outsourcing production and clinical trials, Cara Therapeutics Inc (TVRD) minimizes capital expenditures while maintaining high operational flexibility. The trend in cash per share reflects the actual liquidity reserve, allowing investors to distinguish fundamental value from illusory cheapness and timely identify systemic business degradation by analyzing abnormal liquidity spikes on this chart.